Canada markets closed

Verve Therapeutics, Inc. (VERV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.41+0.26 (+4.23%)
At close: 04:00PM EDT
6.41 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 537.95M
Enterprise Value -11.10M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)34.99
Price/Book (mrq)0.90
Enterprise Value/Revenue -0.94
Enterprise Value/EBITDA 0.05

Trading Information

Stock Price History

Beta (5Y Monthly) 1.70
52-Week Change 3-62.06%
S&P500 52-Week Change 322.38%
52 Week High 321.42
52 Week Low 35.84
50-Day Moving Average 311.08
200-Day Moving Average 312.84

Share Statistics

Avg Vol (3 month) 31.32M
Avg Vol (10 day) 31.07M
Shares Outstanding 583.92M
Implied Shares Outstanding 683.92M
Float 866.94M
% Held by Insiders 17.62%
% Held by Institutions 186.89%
Shares Short (Apr 15, 2024) 415.69M
Short Ratio (Apr 15, 2024) 49.39
Short % of Float (Apr 15, 2024) 422.36%
Short % of Shares Outstanding (Apr 15, 2024) 418.70%
Shares Short (prior month Mar 15, 2024) 414.1M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,048.76%

Management Effectiveness

Return on Assets (ttm)-19.48%
Return on Equity (ttm)-34.78%

Income Statement

Revenue (ttm)11.76M
Revenue Per Share (ttm)0.18
Quarterly Revenue Growth (yoy)408.30%
Gross Profit (ttm)N/A
EBITDA -217.67M
Net Income Avi to Common (ttm)-200.07M
Diluted EPS (ttm)-3.12
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)623.95M
Total Cash Per Share (mrq)7.46
Total Debt (mrq)74.91M
Total Debt/Equity (mrq)12.49%
Current Ratio (mrq)17.24
Book Value Per Share (mrq)7.31

Cash Flow Statement

Operating Cash Flow (ttm)-149.55M
Levered Free Cash Flow (ttm)-110.19M